Neuroprotective effect of echinoside on MPTP-induced Parkinson's disease mouse model by activation of NRF2/HO-1 pathway

Neuroprotective effect of echinoside on MPTP-induced Parkinson's disease mouse model by activation of NRF2/HO-1 pathway

Echinacoside, a principal active compound derived from Cistanche deserticola Ma, is recognized in traditional Chinese medicine for its anti-aging, immunomodulatory, endocrine-regulating, and neuroprotective properties. However, the specific neuroprotective mechanisms of echinacoside remain largely u...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zimeng Li, Hongyan Li
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	Pharmacological Research - Modern Chinese Medicine
Subjects:	Traditional Chinese medicine components Echinacoside Parkinson's disease mouse model
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667142524001672
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Formononetin Exerts Neuroprotection in Parkinson’s Disease via the Activation of the Nrf2 Signaling Pathway
by: Xiaotong Wang, et al.
Published: (2024-11-01)

Echinacoside Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease by Inhibiting Ferroptosis via Nrf2/HMOX1 Pathway
by: Yiming Yan, et al.
Published: (2024-11-01)

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson’s Disease
by: Dongping Huang, et al.
Published: (2017-01-01)

Neuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson’s Disease: Involvement of the PI3K/Akt/GSK3β Pathway
by: Wei Zhang, et al.
Published: (2016-01-01)

Alternative Therapies for Non-Motor Symptoms in Parkinson’s Disease: A Mini Review
by: Liu H, et al.
Published: (2024-12-01)

Squalamine as a Potential Neuroprotective Agent in Parkinson's Disease Related Cognitive Decline
by: Dipesh Pokharel, et al.
Published: (2024-11-01)

Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic Implications
by: Mengru Liu, et al.
Published: (2025-01-01)

Neuroprotective Role of Transchalcone in Parkinson‘s Disease through AMP-activated Protein Kinase-mediated Signaling Pathway
by: Yao Cheng, et al.
Published: (2024-12-01)

Insights into Lipid Metabolism and Composition in Parkinson’s Disease Pathogenesis
by: Pei Xiaoxue, et al.
Published: (2024-11-01)

Neuroprotective effects of GLP-1 class drugs in Parkinson’s disease
by: Dongliang Lv, et al.
Published: (2024-12-01)

Effet de l'illumination proche infra-rouge intracérébrale chez des primates MPTP
by: Fannie Darlot, et al.
Published: (2015-03-01)

Effects of exercise training on nigrostriatal neuroprotection in Parkinson’s disease: a systematic review
by: Shahid Ishaq, et al.
Published: (2025-01-01)

Protective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model
by: Jennifer Barber-Singh, et al.
Published: (2011-01-01)

Neuroprotective effects of gastrodin in both in vivo and in vitro models of Parkinson's disease: Mechanisms from the perspective of oxidative stress, ferroptosis, and cellular senescence
by: Shanshan Li, et al.
Published: (2025-02-01)

Physical exercise-mediated neuroprotective mechanisms in Parkinson's disease, Alzheimer's disease, and epilepsy
by: R.A. Pinho, et al.
Published: (2024-11-01)

The Impact of Physical Activity on Neuroprotection in Neurodegenerative Diseases: A Special Focus on Parkinson’s Disease
by: Aleksandra Buczek, et al.
Published: (2024-12-01)

Glycolytic pathways: The hidden regulators in Parkinson's disease
by: Jing Shen, et al.
Published: (2025-02-01)

Periplaneta americana L. extract exerts neuroprotective effects by inhibiting endoplasmic reticulum stress via AKT-dependent pathway in experimental models of Parkinson’s disease
by: Ting Cao, et al.
Published: (2024-11-01)

Characterizing Secondary and Atypical Parkinsonisms: Defining Features and Clinical Variability
by: Iraís Viveros-Martínez, et al.
Published: (2024-11-01)

Effects of exercise training on the nigrostriatal glutamatergic pathway and receptor interactions in Parkinson’s disease: a systematic review
by: Shahid Ishaq, et al.
Published: (2025-02-01)

Melittin - the main component of bee venom: a promising therapeutic agent for neuroprotection through keap1/Nrf2/HO-1 pathway activation
by: Cong Duc Nguyen, et al.
Published: (2024-11-01)

HDAC6 inhibitor-loaded brain-targeted nanocarrier-mediated neuroprotection in methamphetamine-driven Parkinson's disease
by: Khang-Yen Pham, et al.
Published: (2025-02-01)

New molecular mechanisms to explain the neuroprotective effects of insulin-like growth factor II in a cellular model of Parkinson’s disease
by: Silvana-Yanina Romero-Zerbo, et al.
Published: (2025-01-01)

A Mouse with a Monoclonal Primary lmmunoglobulinRepertoire not Further Diversified by V-GeneReplacement
by: Marilia Cascalho, et al.
Published: (1999-01-01)

Integrated network pharmacology and transcriptomics to explore the mechanism of compound Dihuang granule (CDG) protects dopaminergic neurons by regulating the Nrf2/HMOX1 pathway in the 6-OHDA/MPP+-induced model of Parkinson’s disease
by: Xue Sun, et al.
Published: (2024-12-01)

Akkermansia muciniphila identified as key strain to alleviate gut barrier injury through Wnt signaling pathway
by: Xin Ma, et al.
Published: (2025-02-01)

Assessing the neuroprotective potential of Eucalyptus globulus essential oil in a 6-hydroxydopamine rat model of Parkinson's disease
by: Aracely Janneth Naranjo-Viteri, et al.
Published: (2025-03-01)

TFE3-mediated neuroprotection: Clearance of aggregated α-synuclein and accumulated mitochondria in the AAV-α-synuclein model of Parkinson's disease
by: Xin He, et al.
Published: (2025-03-01)

Combination of tauroursodeoxycholic acid, co-enzyme Q10 and creatine demonstrates additive neuroprotective effects in in-vitro models of Parkinson’s disease
by: Alexander Shtilbans, et al.
Published: (2024-12-01)

Characterization of Walnut Oil and Evaluation of Its Neuroprotective Effects in an In Vitro Model of Parkinson’s Disease
by: Monica Filaferro, et al.
Published: (2024-12-01)

Temporal dynamics in gastrointestinal helminth infections of sympatric mouse lemur species (Microcebus murinus and Microcebus ravelobensis) in Northwestern Madagascar
by: Annette Klein, et al.
Published: (2024-12-01)

Instrumental balance assessment in Parkinson's disease and parkinsonism. A systematic review with critical appraisal of clinical applications and quality of reporting
by: Andrea Merlo, et al.
Published: (2025-01-01)

Uncovering the neuroprotective powers of Allium sativum: exploring its potential to alleviate malathion- associated Parkinson\'s-like behavioral symptoms in a rat model
by: Bahareh Sadat Yousefsani, et al.
Published: (2024-03-01)

Small Molecules in Parkinson’s Disease Therapy: From Dopamine Pathways to New Emerging Targets
by: Hwayoung Lee, et al.
Published: (2024-12-01)

Preliminary Diagnosis and Characterization of a Spontaneous Immature Testicular Teratoma in an Interferon Receptor-Deficient Mouse Model
by: ZHAO He, et al.
Published: (2024-12-01)

<i>Eugenia uniflora</i> Effects on the Depressive-like Behavior of MPTP-Exposed Female Rats: Apoptosis and α-Synuclein Modulation
by: Anne Suély Pinto Savall, et al.
Published: (2025-01-01)

Getah virus triggers ROS-mediated autophagy in mouse Leydig cells
by: Fengqin Li, et al.
Published: (2025-01-01)

Peculiarities of the molecular composition of heterochromatin associated with pronucleoli in mouse embryos
by: I. O. Bogolyubova, et al.
Published: (2019-03-01)

Risk factors for falls in Parkinson's disease and other parkinsonisms
by: Aleksandra Buczek, et al.
Published: (2024-12-01)

Development of Asthma Mouse Model By Dermal Sensitization
by: Isameldin Abdalla, et al.
Published: (2024-12-01)